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Abstract
Background: Many low and middle income countries are implementing reforms to support Universal Health
Coverage (UHC). Perhaps one of the most ambitious examples of this is Indonesia’s national health scheme known
as the JKN which is designed to make health care available to its entire population of 255 million by end of 2019. If
successful, the JKN will be the biggest single payer system in the world. While Indonesia has made steady progress,
around a third of its population remains without cover and out of pocket payments for health are widespread even
among JKN members. To help close these gaps, especially among the poor, the Indonesian government is currently
implementing a set of UHC policy reforms that include the integration of remaining government insurance
schemes into the JKN, expansion of provider networks, restructuring of provider payments systems, accreditation of
all contracted health facilities and a range of demand side initiatives to increase insurance uptake, especially in the
informal sector. This study evaluates the equity impact of this latest set of UHC reforms.
Methods: Using a before and after design, we will evaluate the combined effects of the national UHC reforms at
baseline (early 2018) and target of JKN full implementation (end 2019) on: progressivity of the health care financing
system; pro-poorness of the health care delivery system; levels of catastrophic and impoverishing health
expenditure; and self-reported health outcomes. In-depth interviews with stakeholders to document the context
and the process of implementing these reforms, will also be undertaken.
Discussion: As countries like Indonesia focus on increasing coverage, it is critically important to ensure that the
poor and vulnerable - who are often the most difficult to reach – are not excluded. The results of this study will not
only help track Indonesia’s progress to universalism but also reveal what the UHC-reforms mean to the poor.
Keywords: Universal health coverage, Financing, Equity, Benefit incidence, Financing incidence, Catastrophic health
spending, Impoverishing health spending
Introduction
Concerns about the poor and most vulnerable not get-
ting adequate access to quality health care are wide-
spread in low and middle-income countries (LMICs)
and have led to an intense advocacy for universal health
coverage (UHC). Equity, defined by the World Health
Organization as ‘the absence of avoidable or remediable
differences among groups of people, whether those
groups are defined socially, economically, demographic-
ally, or geographically’ [1] - is fundamental to UHC.
However, emerging evidence is showing that without ad-
equate focus on the measurement of equity, vulnerable
populations may continue to receive inadequate or infer-
ior health care [2].
Financial barriers are a major hindrance to accessing
quality health services [3–5]. The World Health Report
2000 emphasises that a key dimension of a health sys-
tem’s performance is the fairness of its financing system
[1]. Globally, some 100 million people fall below the
poverty line every year as a result of out-of-pocket ex-
penditures on health, and a further 1.2 billion, already
living in poverty, are pushed deeper into it [1]. In coun-
tries such as Pakistan, Laos, The Philippines, Bangladesh,
Indonesia and Vietnam, out-of-pocket payments repre-
sent around 50% or more of total health expenditure [1].
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Moreover, some countries reported to have achieved
universal coverage by prepayment schemes, such as
China and Brazil, still experience high prevalence of
catastrophic health spending and medical impoverish-
ment [6, 7].
UHC has been defined by the 2005 World Health As-
sembly as “access to key promotive, preventive, curative
and rehabilitative health interventions for all at an af-
fordable cost, thereby achieving equity in access” [8]. Ef-
fective implementation of UHC requires equity in health
care, defined as payment for health services according to
capacity to pay and the receipt of benefits according to
need [9]. This implies that the allocation of government
health spending needs to be focused on the poor, and
recognises differences in the cost of accessing health
care by different geographic, demographic and
socio-economic groups. There is evidence that primary
health care is pro-poor, suggesting a greater investment
in these services, along with the removal of barriers to
accessing care, can enhance equity [10]. In many LMICs,
however, government health spending tends to concen-
trate on inpatient hospital services, most of which is
urban-based and often too costly to be accessed by the
poor [10].
A pro-poor publicly financed health-care system is par-
ticularly important given the growing pluralism of
health-care systems in LMICs [11]. Households in LMICs
use a wide range of public and private health-care pro-
viders, many of whom are not regulated by national health
authorities [12] and may be paid for directly by
out-of-pocket payments [13]. Such direct payments affect
the poor more than the rich and tax financed health-care
may protect the most vulnerable against the risk of finan-
cial catastrophe in times of illness [14, 15]. Dual practice –
whereby health workers combine salaried, public-sector
clinical work with a fee-for-service private clientele - is
common in LMICs such as Indonesia and is reported to
play a key role in undermining access to public services,
especially by the poor [16]. Other motivations for univer-
sal health-care include redressing historical inequities in
the distribution of health-care, reducing health inequality
and raising the human capital of the poor and thereby the
growth potential of the economy [17]. Governments
worldwide are seeking to develop their health financing
systems in ways that ensure - and, critically, sustain - uni-
versal coverage [18, 19].
The Indonesian context
Indonesia is a lower middle-income country with a
Gross National Income (GNI) per capita of US$3630
[20] with high Gross Domestic Product (GDP) growth,
averaging 5.6% between 2007 and 2016 [21]. It is the
third most populous country in Asia and the fourth lar-
gest in the world with around 255 million people [20].
Like other LMICs, Indonesia faces significant challenges
in the health sector despite notable progress in the past
decades especially in relation to improved life expect-
ancy. Indonesia’s maternal mortality ratio (MMR) re-
mains one of the highest in Southeast Asia, estimated at
359 per 100,000 live births in 2012 [22]; this is signifi-
cantly higher than the MMR in neighbouring countries -
Malaysia (29 per 100,000 in 2013) and Thailand (26 per
100,000 in 2013) [23]. With neonatal mortality
remaining high at 19 per 1000 live births [21], Indonesia
has the 8th highest number of neonatal deaths in the
world and large disparities between the wealthiest (10
neonatal deaths per 1000 live births) and poorest quin-
tiles (29 per 1000) [23, 24]. Malnutrition is a major
problem with around 37% (8.4 million) of children under
five years being stunted while overweight and obesity in
adults has doubled in the past decade [25, 26]. Indonesia
also faces a double burden of disease characterised by
rising non-communicable diseases and a high incidence
of communicable diseases [27].
Underpinning these problems are significant dispar-
ities in access to quality health services across geo-
graphic regions and socioeconomic groups. For example,
health outcomes are lower in many Eastern Indonesian
provinces as well as in rural areas and among people
from the lowest wealth quintile [22]. The child mortality
rate is less than 10 per 1000 live births in most provinces
of Java and Sumatera but the rate is 2.5 times higher in
the Eastern province of Maluku and North Maluku [22].
Rural households are reported to have an under-five
mortality rate one-third higher than that in urban house-
holds [22]. High government funding allocations to hos-
pitals (less frequently utilised by poor and disadvantaged
communities) and elevated government spending on
pharmaceuticals has also reduced investment in primary
and promotive health services [27]. Indonesia spends
only slightly more than 2% of its GDP on health, ap-
proximately half the level of other comparable income
countries [28]. About half of all health spending is public
and one-third comes directly from of out of pocket pay-
ments by households [28].
A key response by the Government has been the de-
velopment of a compulsory national health insurance
scheme designed to pave the way for the achievement of
universal coverage [29]. This scheme, known as Jaminan
Kesehatan Nasional (JKN), seeks to make comprehen-
sive care available to the entire population by 2019. The
JKN brings together all major health insurance schemes
(Askes, Jamkesmas, Jamsostek and Jamkesda) under a
single agency - the Social Security Management Corpor-
ation for the Health Sector (BPJS Kesehatan) [30]. Prior
to this, Indonesian healthcare was highly fragmented
with private insurance schemes for those who could af-
ford it, basic state provision for the very poorest, and
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NGOs in specialised areas providing support in between.
Through the JKN, the Indonesian Government sought to
improve the situation for the ‘missing middle’, those citi-
zens too poor to afford health insurance but deemed not
poor enough for government support (7).
Indonesia has made steady progress with around 165
million people now members of the JKN, making it the
biggest single-payer health system in the world [31].
There is however mounting evidence of areas where the
JKN is underperforming and without action, the JKN is
unlikely to reach expected levels of population coverage,
service coverage or financial protection by 2019. It is es-
timated that 90 million (40% of the population) remain
uncovered, most of these working in the informal sector
[32]. JKN members continue to incur high out-of-pocket
health expenditures [33]. Moreover, Indonesia’s public
health financing remains at roughly half the estimated
requirement for UHC [32].
Responding to the current challenges facing the JKN,
the Indonesian government is initiating and strengthening
several important reforms ranging from re-structuring
provider payment schemes through to socialization cam-
paigns to raise awareness of the scheme and its benefits
[34]. Strategies for increasing fiscal space for health
through increasing tobacco tax and the phasing out of
subsidies on fuel are also proposed [30]. Our study investi-
gates the equity impact of this latest phase of
UHC-reforms that are designed to provide affordable
health care to all citizens by 2019.
Research objectives
The over-arching goal of this study is to assess the
equity impact of the most recent package of UHC re-
forms implemented by the Indonesian government to
support universal coverage. Specific study objectives are
to:
1) Measure and compare key equity outcomes -
including health care utilisation, subsidies received
through the use of health services, payments people
make for health care, andself-assessed health – in
early 2018 (study baseline) and end of 2019 (target
of JKN full implementation);
2) Develop and apply ‘quality-weightings’ to the
benefits of health spending, to account for variation
in the quality of health services utilised;
3) Document the changing context and processes for
implementing UHC-reforms in Indonesia.
Methodological approach
Health equity research is typically concerned with four
broad sets of outcomes: health care utilisation; subsidies
received through the use of services; payments people
make for health care (through for example, out-of-pocket
payments, insurance premiums and direct and indirect
taxes) [35, 36] and health status. In the case of health sta-
tus, utilisation, and subsidies, the focus is on inequality,
often defined as inequalities between the poor and the
better-off [36]. In the case of health care payments, ana-
lysis tends to focus on progressivity (how much larger
payments are as a share of income for the poor than for
the better-off), the incidence of catastrophic payments
(those that surpass a certain threshold), or the incidence
of impoverishing payments (those that push a household
over the poverty line). This methodological approach and
associated outcomes to be measured in this study are
summarised in Fig. 1.
The study will use a before and after design that em-
ploys both quantitative and qualitative methods. Out-
comes will be evaluated at baseline (early 2018) and at
end of target year of JKN full implementation (end
2019). The UHC reforms, consisting of multiple mea-
sures being progressed simultaneously over the next
2 years, will be evaluated as a ‘package’. While it will not
be possible to draw conclusions concerning individual
components, the study will disaggregate results by socio-
economic status, gender, levels of care and types of
health care providers.
Health care utilisation and distribution of health-care
benefits (objective 1)
Benefit incidence analysis (BIA) measures the extent to
which different groups benefit from public financing for
health through their use of health services [37]. Opera-
tionalisation of the technique involves ranking the study
population by a living standard measure, assessing the
rate of utilisation of different health services, estimating
the unit cost of each service, and multiplying the utilisa-
tion rates and unit costs to determine the amount of
subsidy [38]. Direct payments by users are deducted be-
fore arriving at the final amount of government subsidy
[38].
BIA requires data on health service utilisation, the cost
of accessing health-care and socioeconomic status [15].
A cross-sectional household survey will be conducted at
baseline and 18 months into implementation. Indonesia
comprises approximately 17,000 islands divided into 34
provinces and 514 districts and municipalities [22]. The
sampling for the ENHANCE household survey will be
done in stages. First, a stratified sample of 10 provinces
containing 74% of the population will be selected from 34
Indonesian provinces. Stratification of provinces will
maximise representation of the population, capture the
cultural and socioeconomic diversity, and be cost-effective
to survey given the size and terrain of the country. At the
next stage, two districts within each selected province will
be purposively selected based on population density and
fiscal capacity. From each district, two sub-districts and
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four villages (two villages per sub-district) will be chosen
to ensure a mixed representation of rural and urban areas,
and varying socio-economic status. Two enumeration
areas (EAs) will then be selected from the villages (total of
80 EAs) using a nationally representative sample frame
from the 2013 SUSENAS, a large-scale multi-purpose so-
cioeconomic survey that covers a nationally representative
sample typically composed of 200,000 Indonesian house-
holds [39]. Within each EA, field teams will randomly se-
lect 88 households based upon listings from the Central
Bureau of Statistics to derive a final sample of 7040 house-
holds. In each selected household, one woman (the pri-
mary caregiver) or in her absence, the male head will be
interviewed. The sample size will enable the determin-
ation of prevalence for characteristics with a 95% confi-
dence interval and a precision of +/− 1%. Assuming that
12% of households [40] will exceed the threshold of 25%
of total consumption expenditure on health (a commonly
used indicator of payments for health that may have a
catastrophic effect on household wellbeing [41]), we will
be able to detect differences of 5% in characteristics be-
tween households that exceed the threshold and those
that do not, with approximately 80% power and a type 1
error of 5.
Data will be collected electronically using laptops. An
e-questionnaire will be designed using the NOVA Re-
search Company’s Questionnaire Development System
(QDS) 3.0 and administered with the computer-assisted
personal interview (CAPI) program. The questionnaire
will be piloted in selected EAs to test logistics and gather
information to improve the quality and efficiency of the
main survey. Field teams will be trained in e-data collec-
tion and administrative procedures including the content
of the questionnaire, how to save completed interviews
and how to transfer data to the Central Data Processing
Centre for the study. National Health Accounts (NHA)
will be used to estimate the unit cost of different
health-care services, supplemented by Health Facility
Costings [42]. NHA provide a detailed record of how
Indonesia’s health resources are spent, on what services,
and who pays for them. A critique of different national
data sets for equity analysis in the health sector has been
previously published [43].
The population will be ranked by the index and grouped
into quintiles of equal size. Results will be presented in the
form of bar charts indicating the relative share of total
benefits received by socioeconomic quintiles. In addition,
the distribution of benefits as depicted by the concentra-
tion curve (which plots the cumulative percentage of indi-
viduals ranked in ascending order of living standard
against cumulative percentage of health-care utilisation or
payment) will be compared against the 45° line of perfect
equality [36, 38]. Dominance tests will be carried out to
ascertain whether the differences are significant [36]. In
addition to socioeconomic status, the distribution of
health spending will also be explored by geographic loca-
tion and by gender. The gender dimension of benefit from
health spending is particularly important given the role of
women as primary caregivers in times of illness or disabil-
ity [44].
Socioeconomic status
The ENHANCE household survey will also collect infor-
mation on household asset ownership to enable the con-
struction of an asset index. This type of proxy measure
of socio-economic status has been widely used by inter-
national development agencies such as the World Bank
to assess and monitor health inequalities in LMICs [45].
Fig. 1 Methodological approach
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The asset index will be constructed using principal com-
ponent analysis [46] and based on a range of assets
reflecting housing, utilities and livestock ownership.
Distribution of the burden of paying for health-care
(objective 1)
Financing incidence analysis (FIA), also known as pro-
gressivity analysis, will be used to assess how the burden
of health financing is distributed in relation to house-
hold ability to pay (ATP) [47]. We will measure the pro-
gressivity of each individual source of financing and for
the health financing system as a whole [47]. Financing
sources are deemed progressive (regressive) if the rich
contribute a relatively higher (lower) proportion of their
income to health-care financing than the poor [48].
The 2012 National Socioeconomic Survey (SUSENAS)
of Indonesia and the 2014 National Health Account
(NHA) data will be used to estimate the baseline
health-care financing mix and household contributions
to health financing through direct and indirect taxation,
out-of-pocket payments and payment of health insur-
ance premiums. Evaluation in 2019 will use data from
the 2016 NHA (available in early 2019) and the
2018SUSENAS. District Health Account Data (DHA),
and other relevant cost data produced by BPS-Statistics
will also be used for selected districts where appropriate.
Tax thresholds and actual revenue generated through
different forms of taxation will be obtained from the Na-
tional Taxation Directorate and the Ministry of Finance
and will in turn be triangulated with estimated tax rev-
enue from the NHAs.
Progressivity of health care payments will be assessed
by calculating the Kakwani Index [49], which is the dif-
ference between the concentration coefficient of health
care payments and the Gini coefficient of household ex-
penditure [47, 49]. The value of this index ranges from
− 2 to 1 with a positive Kakwani index indicating that
the health care financing system is progressive, or re-
gressive if negative. A Kakwani index of zero indicates
proportionality of health care payments [49]. The Kak-
wani Index will be calculated for each source of finance.
The progressivity of the overall health financing system
will be calculated by taking a weighted average of the
Kakwani indices of the individual financing sources,
where the weights are the shares of total revenues com-
ing from each source.
Ability to pay
Adult equivalent consumption expenditure will be used
as the measure of ability to pay. Consumption expend-
iture is generally considered a better measure of ability
to pay than income in LMICs with a large informal
sector, as consumption expenditure is smoothed over
time and so better reflects long-term average well-being
[50, 51]. For a detailed critique of different approaches
to measuring ability to pay see O’Donnell et al. [36].
Household consumption expenditure will be translated
into per adult equivalent household consumption, using
the following formula:
AE = (A + αK)θ Where A is the number of adults in
the household, θ is the cost of children, K is the number
of children and the degree of economies of scale [36,
51]. The values of α and θ were assumed to be 0.5 and
0.75, respectively [51, 52].
Catastrophic and impoverishing health care payments
(objective 1)
Out-of-pocket health expenditure exposes households to
the risk of incurring large medical bills that can push
households into financial catastrophe [53]. This is of
major concern to countries such as Indonesia where
more than 28 million people currently live below the
poverty line and around 100 million remain vulnerable
to falling into poverty, as their income hovers marginally
above the national poverty line [54]. Measuring the cata-
strophic and impoverishing effects of out-of-pocket
spending is therefore another important area of health
equity research [36]. In line with other equity analyses
[17, 53], households in this study will be considered to
have incurred catastrophic health expenditure if the
share of health expenditure in the household’s non-food
expenditure is greater than a given threshold often
around 25% [4] or within a range of 10 and 40% [54–
56]. Indicators of catastrophic health expenditure will in-
clude catastrophic head count (share of households in
the population whose health care costs expressed as a
proportion of income exceed the threshold), catastrophic
payment overshoot (average level by which payments, as
a proportion of income, exceed the threshold) and the
mean positive gap (payments in excess of the threshold
average over all households) [36]. The data for this ana-
lysis will come from the 2013 SUSENAS Socioeconomic
Survey conducted by the national Bureau of Statistics
and the ENHANCE cross-sectional survey of Indonesian
households (see section ii). Impoverishment will be
assessed using both national and international poverty
lines of US$1.90 and US$3.10 per day, respectively.
Self-assessed health outcomes (objective 1)
While there is scepticism about the use of subjective
health measures rather than more objective measures
[57, 58], the former are much more readily available to
researchers but more importantly, there exist robust
findings of positive correlations between subjective as-
sessments of health (SAH) and actual health and mortal-
ity [59, 60]. SAH has also been shown to be a good
proxy for health service use in several countries [61].
The ENHANCE cross-sectional household survey (see
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section ii) will ask households to evaluate the general
health condition of individual household members. A
five-point scale with the following response options:
‘very good, good, fair, bad, and very bad’ will be piloted
for use in this study [62]. SAH will be assessed at base-
line in 2017 and 2 years into implementation in 2019.
The measurement of SAH will be designed to enable
comparison with existing measures used in other na-
tional health surveys in Indonesia such as the Basic
Health Research Survey (Riskesdas). In addition to using
SAH as one of the key outcome measures for this study,
it will also be used in the BIA - whereby the distribution
of benefits from using services will be compared with
the distribution of the need for health care, using SAH
as a proxy for need [38]. Several national surveys in
LMICs include questions on SAH as proxies of
health-care need [10].
Socio-economic status
As for the BIA, an asset index will be used to rank
households according their socioeconomic status.
Weighting the benefits of health spending to reflect
quality of services (objective 2)
A recent systematic review of BIA studies in LMICs
found that few studies account for variation in the qual-
ity of services received [10]. This is despite repeated calls
for more precise measures of benefit/subsidy distribu-
tion that reflect the quality of services received [10, 37,
63].In this study benefits received by individuals will be
weighted to reflect the quality of health services utilised,
thereby providing a more precise measure of subsidy
distribution. This is especially important in LMICs
where it is recognised that the poor typically utilise
lower quality health services compared to the rich [64].
The Institute of Medicine defines quality of care as the
‘degree to which health services for individuals and pop-
ulations increase the likelihood of desired health out-
comes and are consistent with current professional
knowledge’ [65]. Measures of healthcare quality have
been divided into 3 domains: structure or inputs to care,
process or content of care, and outcomes of care [66].
According to Leslie and colleagues, each domain has its
pros and cons: inputs are the necessary foundations for
care but are not sufficient to describe its content or ef-
fects, process measures pertain directly to care delivery
but are challenging to collect, and outcome measures as-
sess the ultimate goal of the health system but reflect
many factors beyond the health system itself [67]. Infor-
mation on healthcare quality is sparse in LMICs and
many analysts rely on standardised facility surveys that
focus on inputs such as equipment, medicine supplies,
and health workers [67–69]. A recent review of 8500
quality indicators used to assess performance-based
financing programmes showed that over 90% measured
structural aspects of quality [70]. For this study, data on
the utilisation of different health facilities derived from
our own cross-sectional household surveys (see objective
1a) will be linked to national health facility data on
structural quality and staffing of public and private facil-
ities. Two national surveys will be used: the PODES In-
frastructure Census 2012 and the Health Facility Survey
(Rifaskes) 2011. Scores for different structural quality
domains will be derived from these national surveys and
combined to develop a quality of care index from 0 to 1
for each facility.
Understanding the context and process of implementing
UHC-reforms in Indonesia (objective 3)
Document analysis and interviews will be used to under-
stand the UHC policy adoption process. Specifically, we
will develop a chronology of key events in the reform
process and assess stakeholder support and political
feasibility of the UHC-reforms [71, 72]. Key organisa-
tional and institutional documents from the Ministries
of Health and Finance, local government planning and
health offices, the private sector, the national social
health insurance agency, and multilateral and bilateral
agencies operating in Indonesia will be examined and
interpreted in order to elicit meanings, gain understand-
ing and develop empirical knowledge about the context
within which UHC reforms have been pursued. In
addition, in-depth interviews with approximately 15–20
key stakeholders will be conducted annually to under-
stand the shifting power and positioning of different
stakeholders around key elements of the UHC-reforms
[72]. Stakeholders will be purposively sampled from
Ministries of Health and Finance, health-care managers,
professional associations, donors and private providers
of health-care. Especially important will be the inclusion
of members of the National Social Security Council
(DJSN) which has legal authority to harmonise the JKN
[73]. Interviewees will be chosen from two provinces fa-
cing distinctly different types of UHC implementation
challenges including different levels of technical skills
and management capabilities. These indicators will be
obtained from the PODES Infrastructure Census 2012.
Discussion
This study, evaluating pro-poor health care reforms in
Indonesia, comes at an opportune time given the cen-
trality of equity to the Sustainable Development Goals
(SDGs). It will not only provide evidence on the
equity-impact of Indonesia’s latest UHC-reforms but it
will also help to advance metrics for UHC measurement.
A variety of data sources (primary and secondary) are
being pooled for this analysis. Drawing from a broader
range of data will strengthen country estimates and
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better represent progress to UHC. Furthermore, this
study will be one of the first to reflect the quality of ser-
vices when calculating the distribution of public subsid-
ies for health; an important methodological development
in the field of health equity analysis. Taking account of
the variation in the value of subsidies is especially im-
portant in countries such as Indonesia where around
half of the population live in rural areas with limited ac-
cess to skilled health workers and quality medicines.
Moreover, like many other countries in the region
Indonesia has a thriving private sector with two-thirds
of health financing and more than half of all health ser-
vices in private hands [74]. For the poor, this translates
into high out-of-pocket payments that in turn limits ac-
cess to health care and pushes many into poverty [1]. It
may also place a disproportionate burden on them as
they contribute a high proportion of their income to-
wards health care financing compared to the rich. By
taking a whole of system approach to the evaluation of
UHC reforms, our financial and benefit incidence ana-
lyses will provide a comprehensive picture of the burden
for paying for health services and the extent to which
this ‘mixed’ public-private health system is meeting its
equity goals. Also through our interviews with stake-
holders we will gain insights into the political viability of
the Indonesian UHC-reforms, an important but often
neglected dimension of health system reform [72]. Apo-
tential limitation of this study is that our cross-sectional
household survey, designed to measure health care util-
isation for the benefit incidence analysis, does not repre-
sent the entire population. We will empirically explore
differences in health care utilisation between our sample
and larger household surveys such as the Indonesian
Demographic Health Survey (which collect less detailed
utilisation data) to better understand the representative-
ness of our sample and generalisability of our findings.
Finally, there is continued debate over the most useful
and appropriate measures to assess the equity impact of
UHC reforms. While this study measures a comprehen-
sive suite of outcomes, such a detailed analysis will not
be feasible, nor necessarily appropriate, for all health sys-
tems. We expect this study will help to prioritise out-
come measures for assessing equity in health systems
reform.
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